AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Webinar: Inspection preparation with a risk-based approach consistent with ICH E6 (R2) requirements

Webinar Recorded July 25, 2018


Presented by Steve Whittaker, Senior Consultant, The Avoca Group, and Grace Crawford, VP Clinical Quality and Compliance, MedImmune.

Session discussions:

  • Comparison of inspections from different regulatory authorities
  • Foci of inspectors
  • First-hand experiences of sponsors to uncover common pitfalls
  • MHRA’s emphasis on conducting a risk-based analysis
  • Compliance with ICH E6 (R2) changes by adapting risk-based tools and methods
  • Effect a risk-based approach to inspection readiness with tried and tested strategies


The Avoca Group’s consulting services are grounded in the leading practices and tools from the Avoca Quality Consortium® and customized to drive measurable improvements to quality and compliance in the execution of clinical trials. To learn more, or to speak with a representative, contact us.